Abetalipoproteinemia Monitoring Systems Market: Overview Abetalipoproteinemia (ABL) is an inborn metabolic disorder. It has a heterogeneous interpreted clinical presentation. The disease can be found 1 in 1,000,000. The name is derived from a typical lack of lipoproteins. The lacking lipoprotein is embedded with a beta electrophoretic mobility on the electrophoresis. In 1950, Kornzweig and...